A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics
About this episode
Dr. Moira Gunn interviews Dr. Arun Swaminathan about a new intervention for ALS being developed by Coya Therapeutics.
On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and Frontotemporal Dementia.
More episodes of BioTech Nation ... with Dr. Moira Gunn
- 50 Years of Genentech...Ashley Magargee, CEO, Genentech
- New treatment being tested for pre-term babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
- Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
- Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.